Additional Fast Trak sites will support cell and gene therapy industry in fast growing markets New online digital CELLT1 course provides cell and gene therapy manufacturing theory Cytiva, a global life sciences leader, is expanding its offering at its Fast Trak research and training facilities in Korea, Japan, Cambridge, UK and Uppsala, Sweden. The expanded offering will […]
State-of-the-art site will enable rapid delivery of engineered cell lines Powering ready-to-use edited cell-line portfolio expansion Enable comprehensive customization for research, diagnostic and therapeutic development Cambridge, UK – Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility in Fremont, CA, which will serve […]
The first completely reusable 3D cell culture microplate on the market Montreal, Canada – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use plastics – from serological pipettes and pipette tips to vials and culture microplates – these […]
Company’s intelligent microfluidics platform can identify virtually any cell type, at frequencies as low as one in a billion MOUNTAIN VIEW, Calif. − Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that it has closed its Series A round of financing with $20 million, […]
Amsterdam, the Netherlands — In their quest of creating safe and effective immunotherapy cancer treatments, LUMICKS and LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell Avidity Analyzer. LAVA Therapeutics […]
GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology company, a spin-off from South Korean biotech company Tiumbio, seeking antibody-based therapeutics for patients who are suffering from unaddressed incurable and rare diseases. The strategic collaboration […]
– Supporting drug development research through the use of HCA and three-dimensional culture models – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has entered into a partnership agreement with InSphero AG, a pioneer in the development of 3D in vitro*1 technologies for drug discovery and safety. The two companies aim to establish […]
Simplify drug efficacy and neurotoxicity evaluation TOKYO, Japan – Ricoh Co., Ltd. (Tokyo, Japan) and Elixirgen Scientific, Inc. (Baltimore, Maryland, USA) have jointly developed assay-ready cell plates, which may dramatically simplify the drug efficacy testing for neurological diseases and the neurotoxicity testing for chemical compounds. This product contains human neurons generated from human induced pluripotent stem […]
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia FREDERICK, Md. — RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions for regenerative medicine, today announced it entered into an exclusive agency agreement with Sartorius Korea Biotech, a subsidiary of the […]
Molecular Imaging Platform Leverages Hyb & Seq Chemistry to Spatially Profile Expression of 1,000+ Genes at Single Cell and Sub-Cell Resolution Across Tissue Samples Available in Technology Access Program in H1-2021 with Commercial Instrument Launch Expected in H2-2022 Details to be Shared During Investor and Analyst Day on Tuesday, December 1st SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
